Franklin Biolabs announced a webinar on non-human primates and preclinical research on September 25, 2026.

At the forefront of genetic and biologic therapy innovation, Franklin Biolabs is a fully integrated preclinical CRO with a proven record of taking breakthrough therapies from concept to clinic. Our mission is to empower innovators by providing cutting-edge platform solutions and end-to-end support across the full development journey, from discovery through commercialization. Our dedicated and experienced team delivers seamless, superior customer service and expert project management, ensuring each partnership achieves its scientific and business goals efficiently. Combining deep expertise in genetic medicines and biologics with a commitment to innovation, we help clients turn pioneering ideas into therapies that change lives. Our expertise resides in three robust business units that work together seamlessly to support your entire project. Vector | CMC | Analytics • Research vector production and process development • Large-scale AAV manufacturing • Custom potency assays development, validation, and testing • Full suite of AAV GMP analytical testing (compendial, USP, etc.), multiple platform assays • Analytical testing for non-AAV products Preclinical | Translational • Rodents and a wide range of non-human primates with uninterrupted supply • Comprehensive pharmacology and toxicology assessments • Histopathology and Histology services • Extensive experience across multiple routes of administration • 100% success rate in filing multiple INDs since 2019 • Full regulatory support Immunology | Bioanalytical • Clinical and non-clinical bioanalysis • Immunogenicity (ADA, Nab, ELISPOT) • Biodistribution and viral shedding • PK and biomarker analysis • Non-GLP, GLP, GCLP, CLIA Contact us today info@franklinbio.com to start a conversation about your upcoming project.